Trials / Recruiting
RecruitingNCT06739759
Ovarian Hyperstimulation Syndrome Prevention
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 19 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Ovarian hyperstimulation is a very hazardous complication of ICSI
Detailed description
Ovarian hyperstimulation could be mild , moderate , severe or marked
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antagonist protocol for IVF | antagonist protocol with triggering by Decapeptyl |
| DRUG | Modified Agonist protocol for IVF with additive treatments as HCQ | giving additive drugs to agonist protocolas HCQ |
Timeline
- Start date
- 2024-11-17
- Primary completion
- 2025-06-30
- Completion
- 2025-07-30
- First posted
- 2024-12-18
- Last updated
- 2024-12-18
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06739759. Inclusion in this directory is not an endorsement.